Medicare Enrolled

Dr. Kimberly Janvier-Withrow, M.D

Student in an Organized Health Care Education/Training Program · Davie, FL
Low-engagement
7630 SW 34TH MNR STE 335, Davie, FL 33328
9544761050
In practice since 2017 (9 years)
NPI: 1336680545 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Janvier-Withrow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Janvier-Withrow? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Janvier-Withrow

Dr. Kimberly Janvier-Withrow is a student in an organized health care education/training program specialist in Davie, FL, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Janvier-Withrow received a total of $2,468 from 29 pharmaceutical and/or device companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Janvier-Withrow is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice $2,468 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 148361 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$2,468
Total received (2018-2024)
Avg $494/year across 5 years
Top 13% in FL for student in an organized health care education/training program
29
Companies
113
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,468 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$428
2023
$722
2022
$884
2021
$418
2018
$16

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$251
MAYNE PHARMA COMMERCIAL LLC
$194
Bayer Healthcare Pharmaceuticals Inc.
$191
MAYNE PHARMA INC.
$173
Myovant Sciences Inc.
$172
Astellas Pharma US Inc
$167
AbbVie Inc.
$167
Evofem Biosciences, Inc.
$152
Exact Sciences Corporation
$112
Daiichi Sankyo Inc.
$96
Ethicon US, LLC
$95
Exeltis, USA Inc.
$90
Bayer HealthCare Pharmaceuticals Inc.
$90
Hologic Sales and Service, LLC
$85
TherapeuticsMD, Inc.
$57
Organon LLC
$45
Hologic, LLC
$43
CooperSurgical, Inc.
$41
PFIZER INC.
$34
BIOTISSUE HOLDINGS INC.
$33
Kerecis Limited
$28
Pharmacosmos Therapeutics Inc.
$26
SCYNEXIS, Inc.
$25
MILLICENT US INC
$23
Organogenesis Inc.
$17
Shield Therapeutics Inc
$17
Merck Sharp & Dohme Corporation
$16
Sumitomo Pharma America, Inc.
$14
Avion Pharmaceuticals
$13
Top 3 companies account for 25.8% of total payments
Associated products mentioned in payments ›
ACCRUFER · ACESSA PROVU SYSTEM · ANNOVERA · APTIMA · Balcoltra · Cologuard Collection Kit · Endosee · Enseal · FEMRING · INJECTAFER · Kerecis Omega3 SurgiClose · Kyleena · LO LOESTRIN FE · MONOFERRIC · MYFEMBREE · MYOSURE TISSUE REMOVAL DEVICE · NEXPLANON · NEXTSTELLIS · ORIAHNN · ORILISSA · PARAGARD T 380A · PREMARIN · Phexxi · SLYND · STRATAFIX · Veozah
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a student in an organized health care education/training program specialist in Davie?
Compare student in an organized health care education/training programs in the Davie area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
5,940
Per 100K population
305.2
County median income
$74,534
Nearest hospital
HCA FLORIDA UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Janvier-Withrow is a student in an organized health care education/training program specialist, with low-engagement industry engagement in the top 13% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Janvier-Withrow receive payments from pharmaceutical companies?
Yes. Dr. Janvier-Withrow received a total of $2,468 from 29 companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Janvier-Withrow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →